Partnering & Outsourcing Editorial

1. Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation 2/6/2026

   To secure long-term innovation, Ascendis Pharma's Ivanna Rosendal suggests pharma companies should help startup companies through their growing pains.

2. How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together 2/3/2026

   TransCelerate BioPharma's Andy Lee and Janice Change share the lessons they learned bringing disparate voices together for a united purpose.

3. What CROs Do Right Isn't Always Obvious To Research Sites 1/26/2026

   CROs are doing many things right. But it's when that right thing is understood — not just executed — that the impact becomes far greater than compliance alone.

4. Common Issues And Trends In Clinical Research Vendor Qualification 1/21/2026

   Discover the biggest challenges in vendor qualification, including this one misalignment that affected more than half of surveyed respondents.

5. From Lab To Launch: Navigating The Transition To Commercial Readiness 1/13/2026

   Many clinical-stage companies start thinking about commercialization too late. FTI Consulting experts team up to provide guidance on getting started early.

6. Working (Well) With Patient Advocates: The Sponsor POV 1/12/2026

   Aeovian CEO Allison Hulme reflects on Aeovian Pharmaceuticals' partnership with the TSC Alliance and how it’s informed research and development of their first-in-class selective mTORC1 inhibitor. 

7. Working (Successfully) With Pharma: A PAG's Perspective 1/12/2026

   TSC Alliance President and CEO Kari Rosbeck details the patient advocacy group's unique and fruitful relationship with Aeovian Pharmaceuticals in developing the company's first-in-class selective mTORC1 inhibitor for TSC-related refractory epilepsy.

8. CRO Industry Outlook 2026: The Next Stage Of Clinical Trial Transformation 12/30/2025

   Beroe research manager Mathini Ilancheran reflects on the advances in AI, the rise of APAC as a global trial hub, new regulatory expectations, and increasing scientific complexity and forecasts how they will impact CROs in the coming year.

9. 2 Expectations & 2 Warnings For The Year Ahead 12/19/2025

   Just when I thought I was done with 2026 predictions for the clinical trial industry, three members of my editorial board emailed me some great ones, hence, part 3 of this series. What’s interesting is that two of these submissions, coincidentally, are focused on optimism for AI. In contrast, Denise Bronner’s forecast for the coming year is much more … well, dire.

10. 2026 Forecasts From People Smarter Than Me – Part 1 12/12/2025

    In Part 1 of this forecast series, leaders from TransCelerate, Genentech, Clinical Performance Partners, Marketcap Consulting, and others weigh in on what’s coming next — from regulatory pressure and RBQM mandates to BYOT momentum, AI reality checks, and the financial rebound many CROs are betting on.